Questions?
Please contact Sales at: (212) 520-2765 or email PharmaNewsSales@informa.com
Latest From 3M
COVID-19 Testing Boosts Roche Diagnostics Sales In H1
Roche's diagnostics division grew 3% in the first half of 2020 with exploding demand for COVID-19 tests offsetting declines in routine testing.
COVID-19: Pandemic Could Bring Advances In Diagnostics Development, Experts Say
The diagnostics industry could benefit from a greater focus on real-world evidence linked to the COVID-19 pandemic, according to experts from the US FDA and industry.
Interview: German Diagnostics Industry Questions Wisdom Of Reducing Coronavirus Test Reimbursement
German reimbursement of COVID-19 confirmatory tests has been reduced by one third, a decision that has frustrated both the testing labs and the diagnostics manufacturers who jointly provided the basis of the system that kept the coronavirus to within manageable proportions nationally.
COVID-19 Unveils Social Media Might: Is Pharma Listening Hard Enough?
COVID-19 has generated a mind-boggling one billion-plus mentions on social media, unleashing unstructured big data rich in insights. Experts explain why pharma may well want to“listen in” more raptly to such conversations across therapy areas while shaping some aspects of business strategy.
Company Information
- Industry
- Medical Devices
- Pharmaceuticals
-
Pharmaceuticals
- OTC, Consumer
-
Medical Devices
- Consumables, Central Supplies
-
Diagnostic Imaging Equipment & Supplies
- X-ray
- Other Names / Subsidiaries
-
- 3M Company
- Acelity L.P. Inc.
- Crawford Healthcare Holdings Limited
- Kinetic Concepts, Inc.
- M*Modal
- Minnesota Mining and Manufacturing
- Scott Safety
- Semfinder
- Systagenix Wound Management, Limited